Simtra BioPharma Solutions June 2026 Capabilities Update: ADC

Two experienced CDMOs are aligning their strengths to streamline the path from development to commercialization for antibody-drug conjugates (ADCs). By combining deep technical expertise with coordinated, cross-site support, they are building a more connected approach to complex manufacturing programs. Close collaboration enables smoother tech transfers, stronger communication across teams, and greater consistency in outcomes. Real-world examples highlight how integrated project management, analytical development, and testing can reduce friction and keep timelines on track. 

Watch this presentation and learn how two industry-leading CDMOs are united by a shared goal to deliver ADCs more efficiently to the market by:

• Bringing together the extensive experience and expertise of each company
• Coordinating support at each of the partner’s sites, working together closely to ensure smooth transfers
• Providing examples of collaboration from project management to analytical development and testing